- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05990322
Empowering Economically Insecure Parents to Manage Child Anxiety (ProjectEmpower)
Empowering Anxious Parents to Manage Child Avoidance Behaviors: A Randomized Trial of a Single-Session Intervention Targeting Parent Accommodation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Anxiety disorders are among the most common, debilitating forms of childhood psychopathology, affecting 8.3-27.0% of youth before the age of 18 (Costello, Egger, & Angold, 2005). Child anxiety increases risk for psychiatric comorbidities across the lifespan (Copeland, Angold, Shanahan, & Costello, 2014), creates significant burdens for caregivers (Ramos-Cerqueira et al., 2008), and carries societal costs (Beecham, 2014; Bodden, Dirksen, Bögels, 2008). Although numerous interventions have been developed to treat youth anxiety disorders (Kendall, Achenbrand, & Hudson, 2003), up to 82.2% of US youth with anxiety will not receive adequate care (Merikangas et al., 2011). Several reasons may explain this discrepancy, including the length and cost of existing evidence-based interventions (EBIs) and limited accessibility for families in need. As such, there is great need for accessible, scalable interventions that can ameliorate the global burden of youth anxiety, including those that help prevent the onset of anxiety in high-risk children.
The inaccessibility of mental health care to low-SES children is especially problematic given the heightened risk for mental health problems within this population. (Bøe et al., 2011; Keating & Hertzman, 2000; Mendelson et al., 2008). In fact, children and adolescents who are socioeconomically disadvantaged are 3 times more likely to experience mental health difficulties, relative to their more advantaged peers (Reiss, 2013). This may reflect the fact that low SES is closely related to various other risk factors to psychopathology, like weaker family support networks, increased community violence exposure, greater odds of caregivers using harsh discipline strategies, and more exposure to stressful family life events (Everson-Rose et al., 2011; Hill et al., 1996; Shaw et al., 1998; Stein et al., 2003). Access levels vary as well; an examination of nation-wide data of mental health access among adolescents indicate that low-income families are significantly less likely to connect to services (Newacheck et al., 2003). Unfortunately, even when lower-SES youth do access evidence-based treatments, they may benefit less than their more-advantaged peers. It is critical to develop interventions that can not only efficiently target mechanisms most critical to reducing child psychopathology-especially common, impairing problems like anxiety disorders- that are designed for accessibility among historically underserved populations. A simultaneous emphasis on developing and testing child anxiety interventions that are effective and accessible is necessary to adequately serve the lower-SES children and families they are presumably designed to help.
Single-session interventions (SSIs) may offer one potential solution to this gap in care. SSIs include core components of comprehensive EBIs delivered succinctly to improve the odds of access and completion (Schleider & Weisz, 2017a). In a recent meta-analysis of 50 RCTs, SSIs reduced youth mental health problems of multiple disorders, with SSIs targeting child anxiety producing the largest effects (mean g = 0.58; Schleider & Weisz, 2017b). Thus, well-targeted SSIs may offer cost-effective additions or alternatives to traditional care for anxiety in youth. Given that family factors play a crucial role in the etiology of child anxiety, SSIs targeting parents and their interactions with offspring offer a novel approach to preventing youth anxiety (Degnan, Almas, Fox, 2010). Thus, the aim of this project is to test the acceptability and short-term effects of a novel, web-based SSI targeting parental accommodation: a well-established, potentially modifiable risk factor for child anxiety. Results may reveal a promising, targeted approach to scalable child anxiety prevention.
Research shows that parent accommodation can be systematically reduced via psychosocial intervention, and interventions targeting accommodation have helped mitigate child anxiety (Lebowitz, 2014). Translating core components of existing interventions that target parental accommodation into briefer, self-administered SSIs (i.e., those that do not involve a trained therapist) may improve families' access to empirically driven supports for child anxiety. It may also enhance the implementation of mental health interventions by lay providers who frequently interact with children (e.g. teachers and pediatricians). Thus, the goal of this project is to test a web-based, self-guided SSI (Project EMPOWER) targeting parental accommodation in a financially diverse sample.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: JENNA SUNG, MA
- Phone Number: 631-632-7800
- Email: Jenna.sung@stonybrook.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Have at least one child between the ages of 4-10 years old
- Spouse/partner has not taken part of this study before
- Report clinical levels of child anxiety symptoms, per a score above a 7.5 on the Brief SPENCE Children's Anxiety Scale
- Report economic insecurity, indicated by a score less than or equal to 44 on the Consumer Financial Protection Bureau Financial Well-Being Scale (CFPB)
Exclusion Criteria:
- Participant is non-English speaking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Project EMPOWER
Project EMPOWER is a web-based, self-administered SSI for parents that takes about 30 minutes to complete.
The program includes 5 elements, based on current best-practices in SSI design (Schleider, Dobias, Sung, & Mullarkey, 2020) and existing interventions targeting accommodation (Lebowitz & Omer, 2014): (1) an introduction to the program's rationale; (2) psychoeducation around child anxiety and avoidance, along with how parental accommodation can inadvertently maintain child anxiety; (3) information on how parents can better identify children's patterns of avoidance and encourage brave behavior instead; (4) facilitating parents' creation of an "action plan" for promoting brave behavior and reduce avoidance in their own child; (5) a vignette exercise in which parents read about another family's difficulty managing their child's anxiety; parents identify the elements of the anxiety cycle and provide possible solutions to these parents based on what they learned.
|
Experimental Condition
|
Placebo Comparator: Online Resources and Referrals
Online Resources and Referrals (ORR) is an information sheet containing materials about the nature of child anxiety and a list of national resources related anxiety treatment.
ORR does not include any psychoeducational components regarding parental accommodation.
|
Experimental Condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Family Accommodation Scale
Time Frame: Change from Baseline to 2-week and 4-week follow up
|
Family Accommodation Scale is a 9-item measure designed to assess the extent a caregiver accommodate a child's anxiety symptoms; example questions include: "how often did you assist your child in avoiding things that might make him/her more anxious?"
and "have you modified your family routine because of your child's symptoms?"
Items are rated from 0 (never) to 4 (daily).
Scores range from 0-36 with higher scores indicating more frequent parental accommodation
|
Change from Baseline to 2-week and 4-week follow up
|
Perceived pre-to-post SSI change
Time Frame: Immediately after the SSI
|
This two-item measure assesses participants' perceived change in their ability to help their children manage distressing situations and their ability to provide validation to their children from pre- to post-SSI.
Parents in both groups will rate this question on a 5-point scale of 1 (much less able) to 5 (much more able).
|
Immediately after the SSI
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Program Feedback Scale
Time Frame: Immediately after the SSI
|
The program feedback scale asks participants to rate 7 statements regarding acceptability and feasibility; note whether they would recommend this activity to others; and share what they liked and would change about the SSI.
The 7 statements are rated from 0 (Really Disagree) to 5 (Really Agree).
Total score ranges from 0 to 35, with higher scores indicating a more positive program evaluation.
|
Immediately after the SSI
|
Penn State Worry Questionnaire
Time Frame: Baseline
|
16 item self-report questionnaire that asks individuals to rate how typical worry-related problems are for them, from 1 (not at all typical) to 5 (very typical).
Scores range from 16-80; higher scores indicate more severe worry.
|
Baseline
|
Distress Tolerance Scale
Time Frame: Change from Baseline to 2-week and 4-week follow up
|
16 item measure assessing the extent to which one experiences and withstand distressing emotional states.
Each item is rated on a 5-point Likert scale from 1 (strongly agree) and 5 (strongly disagree).
Total score ranges from 16 to 80 with a higher score indicating higher levels of distress tolerance.
|
Change from Baseline to 2-week and 4-week follow up
|
Consumer Financial Protection Bureau Financial Well-Being Scale
Time Frame: Baseline
|
The CFPB Financial Well-Being Scale measures financial well-being as it relates to control over finances, capacity to absorb financial shock, and having the financial freedom to enjoy life.
Parents are asked to answer 10 questions on a 0 to 4 Likert scale to generate a sum score, which is converted into a standardized score.
Scores range from 14 to 95 with higher scores indicating a higher level of measure financial well-being.
|
Baseline
|
Brief SPENCE Children's Anxiety Scale
Time Frame: Change from baseline to 4-week follow-up
|
8-item measure assessing the severity of child anxiety symptoms on 4 domains: generalized anxiety, separation anxiety, panic/agoraphobia, and social anxiety.
Parents are asked to report on how often their child experiences each anxiety symptom on a scale of 0 (never) to 4 (always).
Total score ranges from 0 to 32, with higher scores indicating higher levels of anxiety in each domain.
|
Change from baseline to 4-week follow-up
|
Strengths and Difficulties Scale
Time Frame: Baseline
|
25-item questionnaire that ask parents to answer questions about their 4 to 17 year old child to screen for 5 domains: emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship problems, and prosocial behavior on a scale of 0 (not true) to 2 (certainly true).
Total score ranges from 0 to 40 with higher scores indicating a higher severity of each domain
|
Baseline
|
Parental Stress Scale
Time Frame: Baseline
|
18 item measure of parental stress levels, parents rate on a scale of 1 (strongly disagree) to a 5 (strongly agree) scale on their perceived positive and negative experience of being a parent.
|
Baseline
|
Everyday Discrimination Scale
Time Frame: Baseline
|
5 item questionnaire used to assess subjective experiences of discrimination.
Participants use a scale of 1 (never) to 5 (at least once a week) to rate how often they have experienced discrimination
|
Baseline
|
Patient Health Questionnaire
Time Frame: Baseline
|
Patient Health Questionnaire (PHQ-4) is a 4 item scale measuring anxiety and depression.
Participants rate each statement on a scale of 0 (not at all) to 4 (nearly every day) to rate the severity of their worry and depression
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 00195
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Project EMPOWER
-
WestEdDepartment of Health and Human Services; Urban StrategiesRecruitingStudy Will Examine the Impact of Project WithUnited States
-
Queen Mary University of LondonCompletedThe Initial Aim of This Project is to Perform in Vitro Validation of Neoepitope Candidates Selected From Available Mutanome DataUnited Kingdom
-
University Medical Center GroningenComprehensive Cancer Centre The Netherlands; Dutch Cancer Society; Dutch Institute... and other collaboratorsRecruitingThe Aim of This Project is to Develop and Validate NTCP-models for Complications After nCRT (and Surgical Resection)Netherlands
Clinical Trials on Project EMPOWER
-
Massachusetts General HospitalAIM Youth Mental HealthRecruitingAnxiety DisordersUnited States
-
Stony Brook UniversityCompletedAnxiety DisordersUnited States
-
Göteborg UniversityKarolinska University Hospital; The Swedish Research Council; Swedish Council... and other collaboratorsRecruiting
-
University of RochesterWithdrawnHeart FailureUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Recruiting
-
Pace UniversityNot yet recruitingChronic Disease
-
VA Office of Research and DevelopmentActive, not recruitingBenzodiazepine Dependence | Taking Benzodiazepines for Any Reason for 3 MonthsUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawnInformal CaregiverUnited States
-
National University of Ireland, Galway, IrelandRecruitingMalignant Pleural EffusionIreland